Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001709401-18-000001
Filing Date
2018-03-01
Accepted
2018-03-01 14:14:18
Documents
1
Effectiveness Date
2018-03-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12827
  Complete submission text file 0001709401-18-000001.txt   13861
Mailing Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

EIN.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-306744 | Film No.: 18656169